Healthcare Services Group Inc

Healthcare Services Group Inc(HCSG)股票分析

$25.300

+0.521 (+2.06%)收盤時

Loading chart…
最高
25.320
開盤
24.630
成交量加權均價
24.96
成交量
1.20M
市值
—
最低
24.250
成交金額
29.96M
企業價值/稅息折舊攤銷前利潤(TTM)
13.72

Healthcare Services Group, Inc. is engaged in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. The Company operates through two segments: housekeeping, laundry, linen and other services (Environmental Services), and dietary department services (Dietary). The housekeeping segment consists of managing its customers' housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers' facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers' facilities. The dietary segment consists of managing its customers' dietary departments, which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents.

AI 分析 of Healthcare Services Group Inc (HCSG)

買進

Healthcare Services Group Inc is a good buy right now, trading at $25.30 with a strong recent performance of +19.73% over the past 5 days and a positive earnings surprise of 63.64% in the latest quarter. The acquisition of NEXDINE is expected to add over $150 million in annual revenue, enhancing growth potential significantly. However, the main risk is the recent downgrade from Baird, lowering the price target to $24, which could indicate potential volatility in the near term.

分析師評級(7)

-13.04% 下跌空間
買進
4 買進
3 持有
0 賣出
目前: 25.30
最低
20.00
平均
22.00
最高
24.00

Baird

2026-10-08

目標價

$24

中性

Oppenheimer

2026-08-19

目標價

$28

優於大盤

UBS

2026-07-08

目標價

$30

買進

UBS

2026-04-23

目標價

$27

買進

RBC Capital

2026-04-23

目標價

$24

Sector Perform

估值指標

Healthcare Services Group Inc(HCSG)目前預期本益比為 17.36,5 年平均預期本益比為 20.45。

預期本益比

合理
5 年均值 P/E
20.45
目前P/E
17.36
高估
28.39
低估
12.51

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
10.64
目前EV/EBITDA
13.72
高估
14.13
低估
7.16

預期股價營收比

高估
5 年均值 P/S
0.60
目前P/S
0.80
高估
0.72
低估
0.48

Alphio AI 對 HCSG 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%HCSG

$15.69

情境價格

基

基準

基準 · 50%HCSG

$12.46

情境價格

悲

悲觀

悲觀 · 25%HCSG

$11.18

情境價格

持有 HCSG 的大戶

R

Royce & Associates, LP

+ 持有HCSG

-17.34%

3個月報酬率

事件時間軸

2026-10-21 (ET)

07:30:00

Company Reports Q3 Revenue of $479.6M, Forecasts Q4 Revenue of $535M to $545M

2026-10-07 (ET)

09:30:00

Healthcare Services Group Acquires NEXDINE Hospitality for $93.5M

2026-07-22 (ET)

07:31:00

Company Reports Q2 Revenue of $470.8M

07:30:00

Reaffirms 2026 Growth Outlook

2026-04-22 (ET)

07:10:00

Company Reports Q1 Revenue of $462.8M

資訊

HCSG 常見問題 —— 由 Alphio AI 解答

Healthcare Services Group, Inc. is engaged in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. The Company operates through two segments: housekeeping, laundry, linen and other services (Environmental Services), and dietary department services (Dietary). The housekeeping segment consists of managing its customers' housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers' facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers' facilities. The dietary segment consists of managing its customers' dietary departments, which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. It operates in the Industrials sector (SERVICES-NURSING & PERSONAL CARE FACILITIES industry).

Healthcare Services Group Inc is a good buy right now, trading at $25.30 with a strong recent performance of +19.73% over the past 5 days and a positive earnings surprise of 63.64% in the latest quarter. The acquisition of NEXDINE is expected to add over $150 million in annual revenue, enhancing growth potential significantly. However, the main risk is the recent downgrade from Baird, lowering the price target to $24, which could indicate potential volatility in the near term.

7 analysts cover HCSG: 4 rate it Buy, 3 Hold and 0 Sell. The average price target is 22.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易